{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-026187","form_type":"8-K","ticker":"ALUR","cik":"0001964979","company_name":"ALLURION TECHNOLOGIES, INC.","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.669474+00:00","generated_at":"2026-05-26T22:26:37.035320+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Allurion relaunches balloon in France after ANSM clearance; exploring combo GLP-1 trial","bullets":["ANSM cleared Allurion to resume sales of Allurion Balloon in France, effective immediately (Feb 13, 2025).","France historically represented approximately 15% of Allurion's revenue.","Company plans clinical trial combining balloon with GLP-1s to study prevention of muscle loss during GLP-1 therapy.","Previous study: patients with balloon gained 5.6% lean body mass while losing 14% total weight over 4 months.","Another study: 167 patients lost 15.7% weight with no change in muscle mass."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-026187","json":"https://secwatch.observer/filing/0001193125-25-026187.json","markdown":"https://secwatch.observer/filing/0001193125-25-026187.md","text":"https://secwatch.observer/filing/0001193125-25-026187.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1964979/000119312525026187/0001193125-25-026187-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1964979/000119312525026187/d826753d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:26:37.035320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001628280-26-039424","ticker":"RICK","company_name":"RCI HOSPITALITY HOLDINGS, INC.","filed_at":"2026-06-01T19:08:52+00:00","headline":"RCI Hospitality regains Nasdaq compliance after filing delayed Q1 10-Q","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039424","json":"https://secwatch.observer/filing/0001628280-26-039424.json","markdown":"https://secwatch.observer/filing/0001628280-26-039424.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/935419/000162828026039424/0001628280-26-039424-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/935419/000162828026039424/rick-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001178913-26-002988","ticker":"SLXN","company_name":"Silexion Therapeutics Corp","filed_at":"2026-05-29T11:00:25+00:00","headline":"Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted","event_type":"regulatory","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-002988","json":"https://secwatch.observer/filing/0001178913-26-002988.json","markdown":"https://secwatch.observer/filing/0001178913-26-002988.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/0001178913-26-002988-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/zk2635442.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-240645","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-05-27T13:10:06+00:00","headline":"Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027","event_type":"regulatory","sec_items":["7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-240645","json":"https://secwatch.observer/filing/0001193125-26-240645.json","markdown":"https://secwatch.observer/filing/0001193125-26-240645.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526240645/0001193125-26-240645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526240645/d129501d8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-025171","ticker":"MBOT","company_name":"Microbot Medical Inc.","filed_at":"2026-05-26T12:30:22+00:00","headline":"Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.","event_type":"regulatory","sec_items":["7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025171","json":"https://secwatch.observer/filing/0001493152-26-025171.json","markdown":"https://secwatch.observer/filing/0001493152-26-025171.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/0001493152-26-025171-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001731122-26-000781","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-05-22T12:15:26+00:00","headline":"Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026","event_type":"regulatory","sec_items":["3.01","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000781","json":"https://secwatch.observer/filing/0001731122-26-000781.json","markdown":"https://secwatch.observer/filing/0001731122-26-000781.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/0001731122-26-000781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/e7667_8-k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-065180","ticker":"ADGM","company_name":"Adagio Medical Holdings, Inc.","filed_at":"2026-05-21T20:31:34+00:00","headline":"Adagio submits PMA to FDA for vCLAS VT ablation system; trial shows 97.4% acute success","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-065180","json":"https://secwatch.observer/filing/0001104659-26-065180.json","markdown":"https://secwatch.observer/filing/0001104659-26-065180.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2006986/000110465926065180/0001104659-26-065180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2006986/000110465926065180/tm2614299d2_8k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-064863","ticker":"CGTX","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2026-05-21T11:34:37+00:00","headline":"Cognition Therapeutics completes productive FDA meeting for zervimesine in DLB psychosis","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-064863","json":"https://secwatch.observer/filing/0001104659-26-064863.json","markdown":"https://secwatch.observer/filing/0001104659-26-064863.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926064863/0001104659-26-064863-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926064863/tm2615260d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001410636-26-000094","ticker":"AWK","company_name":"American Water Works Company, Inc.","filed_at":"2026-05-15T20:34:52+00:00","headline":"Kentucky-American Water files $17.7M rate case; shareholders approve charter amendment, equity plan","event_type":"regulatory","sec_items":["5.02","5.07","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001410636-26-000094","json":"https://secwatch.observer/filing/0001410636-26-000094.json","markdown":"https://secwatch.observer/filing/0001410636-26-000094.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410636/000141063626000094/0001410636-26-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410636/000141063626000094/awk-20260513.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}